Long-Lasting Support for
Opioid Addiction Recovery
At IMHNR, we offer Injectable Buprenorphine treatments, including Sublocade and Brixadi, as part of our Medication-Assisted Treatment (MAT) program. These long-acting injections help individuals recovering from opioid addiction manage cravings, reduce withdrawal symptoms, and stay committed to long-term recovery—with the convenience of once-weekly or once-monthly dosing.

Understanding Injectable Buprenorphine
What Is It?
Injectable Buprenorphine is a medication used to treat Opioid Use Disorder (OUD) by partially activating the brain’s opioid receptors without producing a high. This helps reduce the physical effects of withdrawal and cravings while preventing relapse.
Sublocade is administered monthly, while Brixadi offers both weekly and monthly options—providing flexible, sustained support. At IMHNR, we evaluate your clinical needs and lifestyle to determine the best injectable option for your recovery plan.

Tailored for Real Recovery
Conditions Treated with
Injectable Buprenorphine
Injectable Buprenorphine is designed for individuals experiencing:
Opioid Use Disorder (OUD)
Including heroin, fentanyl, oxycodone, hydrocodone, and other prescription opioid addictions.
Relapse Risk After Detox
Ideal for individuals who have completed detox and need long-acting protection during early recovery.
Challenges with Daily Medications
A great option for those who prefer not to rely on daily oral treatments like Suboxone.
Backed by Results
Key Benefits of Injectable Buprenorphine

Consistent medication levels with once-weekly or monthly dosing

Reduces cravings and withdrawal symptoms

Supports long-term adherence to recovery

Eliminates risk of missed doses or misuse

Enhances stability during early and ongoing recovery

Compassion Meets Expertise
Why Choose IMHNR
for Injectable Buprenorphine
At IMHNR, our team of addiction specialists and psychiatric providers creates customized injectable treatment plans based on your needs. We provide medical supervision, ongoing counseling, and full integration with therapy to ensure well-rounded care and accountability.
What we offer:
Sublocade and Brixadi administration by licensed professionals
Ongoing monitoring and check-ins
Integration with therapy and case management
Telehealth support when needed
A safe, stigma-free clinical environment
Start Where You Are
Begin Injectable Treatment with IMHNR
If you’re ready to take a lasting step in opioid addiction recovery, Injectable Buprenorphine (Sublocade or Brixadi) may be the right option. Let the IMHNR team help you build a stable, supported path forward.
Yes, same-day or next-day Sublocade appointments are often available when clinically appropriate.
Our team moves quickly because early treatment lowers relapse risk. After a brief medical evaluation, we can often start treatment without long delays. Patients from Plantation, Davie, Sunrise, and Fort Lauderdale appreciate the fast access and discreet process.
You can receive Sublocade injections at our Plantation, FL office.
We serve patients throughout Broward County, including Davie, Sunrise, and Fort Lauderdale. We have also seen patients traveling from Boca Raton, Boynton Beach, West Palm Beach, and Miami for treatment. Injections are administered in-office by experienced, board-certified providers in a private medical setting. Insurance verification is available before your visit.
Injectable buprenorphine is a monthly medication that treats opioid use disorder by reducing cravings and withdrawal symptoms.
It is a long-acting form of buprenorphine given as an injection under medical supervision. Because it lasts about a month, it removes the need for daily dosing. This helps many patients stay consistent in recovery.
The injectable alternative to Suboxone is a long-acting buprenorphine injection such as Sublocade.
Instead of taking a daily film or tablet, the medication is administered once a month in the office. This reduces missed doses and lowers the risk of misuse. Many patients choose it for structure and convenience.
Suboxone is taken daily, while injectable buprenorphine is given once a month in the office.
Both contain buprenorphine, but the injectable form provides steady medication levels for several weeks. This can reduce daily reminders and improve consistency. Your provider will help determine which option fits your lifestyle and recovery goals.
Neither is universally better. The best option depends on your recovery needs.
Some patients prefer daily control with Suboxone, while others benefit from the structure of a monthly injection. Our board-certified providers create a personalized plan based on your history, stability, and preferences. The goal is safe, steady progress.
Yes, monthly injectable buprenorphine lowers relapse risk by reducing cravings and withdrawal symptoms.
Because the medication stays active for weeks, it provides consistent support during recovery. When combined with therapy and psychiatric care, outcomes improve significantly. Stability increases confidence and long-term success.
Most patients can begin treatment within 24 to 48 hours.
We prioritize fast access because timing matters in recovery. After evaluation, we create a clear plan and begin care as soon as medically appropriate. Early stabilization reduces risk and improves outcomes.
Injectable buprenorphine is safe when prescribed and monitored by a qualified medical provider.
Our board-certified team closely supervises each patient. We monitor response, adjust treatment when needed, and coordinate psychiatric support. Safety and medical oversight are built into every step of care.
Adults diagnosed with opioid use disorder who want a structured, long-acting option may qualify.
A medical evaluation determines eligibility and timing. We assess overall health, treatment history, and recovery goals. Patients across Plantation and Broward County choose this option for added stability.
Treatment length varies based on your individual recovery plan.
Some patients use it during stabilization, while others continue longer for relapse prevention. There is no fixed timeline. We adjust care based on progress and long-term goals.
Most major insurance plans cover injectable buprenorphine treatment.
We accept Medicare and many commercial plans including UnitedHealthcare, Oscar, Aetna, and Florida Blue. Coverage varies, so our team verifies benefits before treatment. This helps reduce surprises and keeps care affordable.
Yes, we provide full medication management alongside injectable treatment.
Many patients have co-occurring conditions such as depression or anxiety. Our integrated psychiatry team monitors mental health and adjusts medications as needed. Comprehensive care improves long-term stability.
Yes, Spanish-speaking staff are available.
We support patients and families in English and Spanish throughout the treatment process. Clear communication improves safety and comfort.
Yes, buprenorphine is available as a monthly injection.
This long-acting form is administered in a medical office and supports recovery without daily dosing. It is FDA-approved and widely used for opioid use disorder treatment.
Most patients need to be stabilized on Suboxone or buprenorphine before starting Sublocade.
This allows your provider to confirm the correct dosage and ensure your body tolerates the medication. Once stabilized, the monthly injection can replace daily dosing. Your provider will guide you through each step safely.
Privacy Policy . Terms & Conditions
© All Rights Reserved Insight Mental Health & Recovery Powered by RewardLion Ai Powered Solutions 2025